Breakpoint cluster region pseudogene 7 (BCRP7)

Breakpoint cluster region pseudogene 7 (BCRP7) is classified as a pseudogene, and not as a protein-coding gene, enzyme, transporter, or drug target. As a pseudogene, BCRP7 is a non-functional genomic DNA sequence originally derived from the BCR gene, but it does not produce a functional protein product. There is no evidence in current biomedical literature or genetic databases for a therapeutic or diagnostic role, disease association, protein expression, or drug interaction related to BCRP7. In general, pseudogenes can occasionally play regulatory roles (such as acting as competitive endogenous RNAs in ceRNA networks)[5][7], but there is no specific evidence available for BCRP7 regarding any such function. Available results focus on the functional BCR gene, not its pseudogenes, so information for BCRP7 is extremely limited or absent[1][2], and most references to pseudogenes discuss general properties rather than specifics for BCRP7. If you require structured information on the protein-coding BCR gene, that would be a different target. Key points: - BCRP7 is not a therapeutic target. - There is no evidence for biological function, disease association, drug targeting, or biomarker status. - The entry is likely only of genomic or transcriptomic interest for researchers cataloging human pseudogenes, not for drug discovery or clinical targeting. If this result is contrary to your expectations (for example, if you intended to target the functional BCR gene or BCR-ABL1 fusion protein), a different canonical name and entry should be used.

Other names

BCR pseudogene 7BCRP7breakpoint cluster region pseudogene 7